Great Basin Scientific, Inc. has unveiled its GB550 enhanced molecular diagnostic analyzer that will allow for faster test times and increased throughput, using streamlined design, intuitive user interface and a smaller footprint.
The GB550 will allow lab technicians to process tests in 75-90 minutes with the potential for some tests to process in less than an hour, and includes an integrated touchscreen and barcode scanner, which decreases the overall footprint and eliminates the need for external cables.
The analyzer features a simplified software interface and will be compatible with all existing and future Great Basin tests and panels, including the company’s tests for Toxigenic Clostridium difficile (C. diff), Group B Streptococcus (GBS), as well as the newly cleared Shiga Toxin Direct Test and the Staph ID/R Blood Culture Panel.
Ryan Ashton, co-founder and CEO of Great Basin said the improved productivity per analyzer increases the company’s potential revenue per instrument by 35-40 percent. The company expects to begin delivery of the new analyzer in the first half of 2017.